Assessments

Pharmaceutical Trade Remains Resilient in the Face of COVID-19

Greg Priddy
Director, Global Energy and Middle East, Stratfor
Apr 8, 2020 | 10:00 GMT
A photo of pill packets. The COVID-19 pandemic has raised serious concerns about the extremely high concentration of global pharmaceutical supply chains sourced from China and India.

A photo of pill packets. The COVID-19 pandemic has raised serious concerns about the extremely high concentration of global pharmaceutical supply chains sourced from China and India.

(Shutterfly/Nenov Brothers Images)

The United States and many other countries are heavily dependent on supplies of pharmaceuticals and precursor chemicals from China and India. Widespread shortages resulting from the COVID-19 outbreak remain unlikely. Legislative proposals in the United States to force companies to "reshore" supply chains will likely falter on the increase in costs and regulatory hurdles. ...

Seek Intelligence Over News - 2021 Annual Forecast is Available!

Subscribe Today for $149!

12-Month Introductory Offer for eligible new & returning subscribers.

  • High quality, unbiased analysis of global events
  • Quarterly, annual, and decade geopolitical forecasts
  • Customized notifications, newsletters, and much more

Preview Some FREE Worldview Articles Below:

Free Coronavirus Articles

Free Geopolitical Articles

Article Search

Copyright © Stratfor, an operating unit of RANE Network Inc.

Stratfor Worldview

OUR COMMITMENT

To empower members to confidently understand and navigate a continuously changing and complex global environment.